Other
Net Change in Cash
Moderna Net Change in Cash decreased by 147.0% to -$688.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 127.1%, from -$303.00M to -$688.00M. Over 2 years (FY 2021 to FY 2025), Net Change in Cash shows a downward trend with a -60.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $161.00M | $0.00 | $1.30B | -$1.80B | -$2.18B | $244.00M | $361.00M | -$869.00M | -$25.00M | -$857.00M | -$833.00M | -$303.00M | -$345.00M | -$147.00M | $1.46B | -$688.00M |
| QoQ Change | — | -100.0% | — | -238.6% | -20.8% | +111.2% | +48.0% | -340.7% | +97.1% | <-999% | +2.8% | +63.6% | -13.9% | +57.4% | >999% | -147.0% |
| YoY Change | — | — | — | — | <-999% | +113.6% | +116.6% | — | — | -451.2% | +4.1% | +64.6% | — | +82.4% | — | -127.1% |
Range-$2.18B – $1.46B
CAGR+47.3%
Avg YoY Growth-206.0%
Median YoY Growth+34.4%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Moderna's net change in cash?
- Moderna (MRNA) reported net change in cash of -$688.00M in Q1 2026.
- How has Moderna's net change in cash changed year-over-year?
- Moderna's net change in cash decreased by 127.1% year-over-year, from -$303.00M to -$688.00M.
- What is the long-term trend for Moderna's net change in cash?
- Over 2 years (2021 to 2025), Moderna's net change in cash has grown at a -60.5% compound annual growth rate (CAGR), from $4.28B to $668.00M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.